| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S9083 |
Global fee urgent care centers |
5,419 |
4,545 |
$405K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,919 |
4,011 |
$350K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,732 |
1,936 |
$223K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
11,659 |
8,362 |
$108K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,168 |
2,219 |
$87K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,792 |
1,187 |
$81K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,731 |
1,011 |
$79K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,367 |
944 |
$75K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
648 |
530 |
$59K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,480 |
1,038 |
$53K |
| 94760 |
|
5,329 |
3,470 |
$52K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
889 |
571 |
$25K |
| 36415 |
Collection of venous blood by venipuncture |
897 |
669 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,418 |
479 |
$17K |
| 99051 |
|
2,797 |
1,941 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,091 |
779 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
455 |
338 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
266 |
145 |
$5K |
| 81000 |
|
141 |
101 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,344 |
914 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
12 |
$351.70 |
| 99000 |
|
1,403 |
989 |
$58.50 |